TW224471B - - Google Patents
Info
- Publication number
- TW224471B TW224471B TW081109247A TW81109247A TW224471B TW 224471 B TW224471 B TW 224471B TW 081109247 A TW081109247 A TW 081109247A TW 81109247 A TW81109247 A TW 81109247A TW 224471 B TW224471 B TW 224471B
- Authority
- TW
- Taiwan
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80116391A | 1991-11-26 | 1991-11-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW224471B true TW224471B (OSRAM) | 1994-06-01 |
Family
ID=25180362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW081109247A TW224471B (OSRAM) | 1991-11-26 | 1992-11-18 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5491216A (OSRAM) |
| EP (1) | EP0544466A1 (OSRAM) |
| JP (1) | JP3304442B2 (OSRAM) |
| KR (1) | KR930009591A (OSRAM) |
| CN (1) | CN1072723A (OSRAM) |
| AU (1) | AU2857692A (OSRAM) |
| BR (1) | BR9204542A (OSRAM) |
| CA (1) | CA2083360A1 (OSRAM) |
| CZ (1) | CZ342492A3 (OSRAM) |
| FI (1) | FI925343L (OSRAM) |
| HU (2) | HU9203688D0 (OSRAM) |
| IL (1) | IL103849A0 (OSRAM) |
| MX (1) | MX9206724A (OSRAM) |
| NO (1) | NO924525L (OSRAM) |
| NZ (1) | NZ245170A (OSRAM) |
| TW (1) | TW224471B (OSRAM) |
| ZA (1) | ZA928916B (OSRAM) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69637130T2 (de) * | 1995-02-20 | 2008-02-21 | The Walter And Eliza Hall Institute Of Medical Research, Parkville | Immunoreaktive und immunotherapeutische moleküle welche in individuen mit insulin-abhängiger diabetes mellitus interagieren |
| DK0821006T3 (da) * | 1996-07-26 | 2004-08-16 | Aventis Pharma Gmbh | Insulinderivater med öget zinkbinding |
| US6444641B1 (en) | 1997-10-24 | 2002-09-03 | Eli Lilly Company | Fatty acid-acylated insulin analogs |
| US6933272B1 (en) | 1998-09-22 | 2005-08-23 | Erik Helmerhorst | Use of non-peptidyl compounds for the treatment of insulin related ailments |
| ES2266187T3 (es) | 2000-03-24 | 2007-03-01 | Genentech, Inc. | Uso de la insulina para el tratamiento de trastornos del cartilago. |
| MXPA04006084A (es) * | 2001-12-20 | 2005-03-31 | Lilly Co Eli | Molecula de insulina que tiene una accion en el tiempo prolongada. |
| EP1620465A2 (en) * | 2003-04-29 | 2006-02-01 | Eli Lilly And Company | Insulin analogs having protracted time action |
| WO2007081824A2 (en) * | 2006-01-06 | 2007-07-19 | Case Western Reserve University | Fibrillation resistant proteins |
| CN101573133B (zh) | 2006-07-31 | 2014-08-27 | 诺沃-诺迪斯克有限公司 | Peg化延长的胰岛素 |
| PL2074141T3 (pl) | 2006-09-22 | 2017-02-28 | Novo Nordisk A/S | Analogi insuliny oporne na proteazę |
| ES2554773T3 (es) | 2006-10-04 | 2015-12-23 | Case Western Reserve University | Insulina y análogos de la insulina resistentes a la fibrilación |
| US9387176B2 (en) | 2007-04-30 | 2016-07-12 | Novo Nordisk A/S | Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein |
| PT2254906T (pt) | 2008-03-18 | 2017-01-03 | Novo Nordisk As | Análogos de insulina acilados, estabilizados contra proteases |
| US8993516B2 (en) * | 2008-04-14 | 2015-03-31 | Case Western Reserve University | Meal-time insulin analogues of enhanced stability |
| WO2009132129A2 (en) * | 2008-04-22 | 2009-10-29 | Case Western Reserve University | Isoform-specific insulin analogues |
| KR20120129875A (ko) * | 2008-07-31 | 2012-11-28 | 케이스 웨스턴 리저브 유니버시티 | 염소화 아미노산을 갖는 인슐린 유사체 |
| US9200053B2 (en) | 2008-07-31 | 2015-12-01 | Case Western Reserve University | Insulin analogues containing penta-fluoro-Phenylalanine at position B24 |
| US8399407B2 (en) * | 2009-09-17 | 2013-03-19 | Case Western Reserve University | Non-standard insulin analogues |
| CA2783763A1 (en) | 2009-12-11 | 2011-06-16 | Case Western Reserve University | Insulin analogues with chlorinated amino acids |
| US9187547B2 (en) * | 2011-03-15 | 2015-11-17 | Novo Nordisk A/S | Human insulin analogues and derivatives comprising cysteine substitutions |
| KR20150002777A (ko) | 2012-04-11 | 2015-01-07 | 노보 노르디스크 에이/에스 | 인슐린 제제 |
| RU2673185C2 (ru) | 2013-10-07 | 2018-11-22 | Ново Нордиск А/С | Новое производное аналога инсулина |
| CN104017809A (zh) * | 2014-06-05 | 2014-09-03 | 山东省农业科学院生物技术研究中心 | 改造的人Insulin蛋白表达基因及表达方法 |
| EP3204410B1 (en) | 2014-10-06 | 2021-01-20 | Case Western Reserve University | Biphasic single-chain insulin analogues |
| CA2979397A1 (en) * | 2015-03-12 | 2016-09-15 | Board Of Trustees Of Michigan State University | Compositions and methods for measuring c-peptide binding and diagnosing immune-mediated diseases |
| KR20170036643A (ko) * | 2015-09-24 | 2017-04-03 | 한미약품 주식회사 | 인슐린의 제조 방법 |
| BR112019011761A2 (pt) | 2016-12-16 | 2019-11-05 | Novo Nordisk As | composições farmacêuticas contendo insulina |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3326473A1 (de) * | 1983-07-22 | 1985-01-31 | Hoechst Ag, 6230 Frankfurt | Pharmazeutisches mittel zur behandlung des diabetes mellitus |
| DE3326472A1 (de) * | 1983-07-22 | 1985-02-14 | Hoechst Ag, 6230 Frankfurt | Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus |
| US4581165A (en) * | 1984-06-14 | 1986-04-08 | Eli Lilly And Company | Anti-diabetic compounds |
| US4569792A (en) * | 1984-06-14 | 1986-02-11 | Eli Lilly And Company | Anti-diabetic compounds |
| US4569791A (en) * | 1984-06-14 | 1986-02-11 | Eli Lilly And Company | Anti-diabetic compounds |
| US5008241A (en) * | 1985-03-12 | 1991-04-16 | Novo Nordisk A/S | Novel insulin peptides |
| DK129385A (da) * | 1985-03-22 | 1986-09-23 | Novo Industri As | Peptider og fremstilling deraf |
| ZA877505B (en) * | 1986-10-14 | 1989-05-30 | Lilly Co Eli | Process for transforming a human insulin precursor to human insulin |
| US4992418A (en) * | 1987-07-17 | 1991-02-12 | Mount Sinai School Of Medicine | Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin |
| EP0347781B1 (de) * | 1988-06-23 | 1994-02-16 | Hoechst Aktiengesellschaft | Mini-Proinsulin, seine Herstellung und Verwendung |
| DE3844211A1 (de) * | 1988-12-29 | 1990-07-05 | Hoechst Ag | Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
| DK134189D0 (da) * | 1989-03-20 | 1989-03-20 | Nordisk Gentofte | Insulinforbindelser |
| DE3936876A1 (de) * | 1989-11-06 | 1991-05-23 | Hoechst Ag | Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
| US5130236A (en) * | 1989-12-07 | 1992-07-14 | Eli Lilly And Company | Process for producing des(64,65)-proinsulin |
| US5139716A (en) * | 1990-02-20 | 1992-08-18 | Loral Aerospace Corp. | Method of fabricating coolable ceramic structures |
-
1992
- 1992-11-18 NZ NZ24517092A patent/NZ245170A/xx unknown
- 1992-11-18 CZ CS923424A patent/CZ342492A3/cs unknown
- 1992-11-18 TW TW081109247A patent/TW224471B/zh active
- 1992-11-18 ZA ZA928916A patent/ZA928916B/xx unknown
- 1992-11-19 CA CA002083360A patent/CA2083360A1/en not_active Abandoned
- 1992-11-20 EP EP92310616A patent/EP0544466A1/en not_active Withdrawn
- 1992-11-23 IL IL103849A patent/IL103849A0/xx unknown
- 1992-11-23 MX MX9206724A patent/MX9206724A/es unknown
- 1992-11-24 HU HU9203688A patent/HU9203688D0/hu unknown
- 1992-11-24 AU AU28576/92A patent/AU2857692A/en not_active Abandoned
- 1992-11-24 HU HU9203688A patent/HUT63457A/hu unknown
- 1992-11-24 KR KR1019920022175A patent/KR930009591A/ko not_active Withdrawn
- 1992-11-24 NO NO92924525A patent/NO924525L/no unknown
- 1992-11-25 FI FI925343A patent/FI925343L/fi not_active Application Discontinuation
- 1992-11-25 BR BR9204542A patent/BR9204542A/pt not_active Application Discontinuation
- 1992-11-25 CN CN92113309A patent/CN1072723A/zh active Pending
- 1992-11-25 JP JP31483692A patent/JP3304442B2/ja not_active Expired - Fee Related
-
1993
- 1993-07-06 US US08/087,831 patent/US5491216A/en not_active Expired - Fee Related
-
1995
- 1995-06-06 US US08/466,945 patent/US5698669A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1072723A (zh) | 1993-06-02 |
| MX9206724A (es) | 1993-05-01 |
| HUT63457A (en) | 1993-08-30 |
| NO924525D0 (no) | 1992-11-24 |
| KR930009591A (ko) | 1993-06-21 |
| NZ245170A (en) | 1994-07-26 |
| HU9203688D0 (en) | 1993-03-29 |
| FI925343A7 (fi) | 1993-05-27 |
| NO924525L (no) | 1993-05-27 |
| FI925343L (fi) | 1993-05-27 |
| AU2857692A (en) | 1993-05-27 |
| CZ342492A3 (en) | 1993-06-16 |
| JPH05286998A (ja) | 1993-11-02 |
| FI925343A0 (fi) | 1992-11-25 |
| CA2083360A1 (en) | 1993-05-27 |
| JP3304442B2 (ja) | 2002-07-22 |
| US5698669A (en) | 1997-12-16 |
| US5491216A (en) | 1996-02-13 |
| EP0544466A1 (en) | 1993-06-02 |
| BR9204542A (pt) | 1993-06-01 |
| ZA928916B (en) | 1994-05-18 |
| IL103849A0 (en) | 1993-04-04 |